Search

Hansen M Hsiung

from San Jose, CA
Age ~77
Get Report
Also known as:
Hansen Lingann Hsiung, Hansen House Hsiung, Hansen Ling Hsiung, Hansen Te Hsiung, Lingann Ann Hsiung, Ling-Ann W Hsiung, Hansen M Hsuing, Hansen M Shiung, N Hsiung, Ann Hsiung Ling
Phone and address:
1691 Four Oaks Rd, San Jose, CA 95131
Related to:
Amy W Hsiung, 47Yvonne O Hsiung, 36Ann Whsiung Ling, 75Amy W Hsiung, 75Lingann Ann Hsiung, 75Autumn M FosseDewanda K Pederson, 61Jason D Fosse, 39Wayne H Hsiung, 43Cassandra S Fosse, 42Shawn A Fosse, 43Amy HsiungWei Ling Yu, 77
Connected to:
Anita C Hsiung, 75Cathy H Hsiung, 55Connie C Hsiung, 95Daniel K Hsiung, 63Edwin Hsiung, 68Emily Hsiung, 74Feng L Hsiung, 60Kenny K Hsiung, 41Richard W Hsiung, 54

Hansen Hsiung Phones & Addresses

  • 1691 Four Oaks Rd, San Jose, CA 95131
  • 3440 Bay Road South Dr, Indianapolis, IN 46240 (317) 913-0621 (317) 844-9792
  • Milpitas, CA
  • Capitola, CA
  • Santa Cruz, CA
  • Carmel, IN
  • 4203 Sea Pines Ct, Capitola, CA 95010 (317) 913-0621

Work

Company: Eli lilly 1980 to 2005 Position: Research advisor

Education

Degree: High school graduate or higher

Interests

Exercise • Sweepstakes • Nascar • Home Improvement • Reading • Sports • Golf • Home Decoration • Health • Cooking • Electronics • Fitness • Music • Dogs • Family Values • Movies • Collecting • Christianity • Medicine • Travel • Career • Investing • Traveling

Resumes

Resumes

Hansen Hsiung Photo 1

Hansen Hsiung

View page
Location:
3440 Bay Road South Dr south, Indianapolis, IN 46240
Work:
Eli Lilly 1980 - 2005
research advisor
Interests:
Exercise
Sweepstakes
Nascar
Home Improvement
Reading
Sports
Golf
Home Decoration
Health
Cooking
Electronics
Fitness
Music
Dogs
Family Values
Movies
Collecting
Christianity
Medicine
Travel
Career
Investing
Traveling

Publications

Us Patents

Methods And Compositions For Regulating Body Weight In Bovine Species

View page
US Patent:
20030082678, May 1, 2003
Filed:
Jul 20, 2001
Appl. No.:
09/910180
Inventors:
Hansen Hsiung - Indianapolis IN, US
Dennis Smith - Indianapolis IN, US
International Classification:
C07K014/705
C12P021/02
C12N005/06
C07H021/04
US Classification:
435/069100, 435/320100, 435/325000, 530/350000, 536/023500
Abstract:
The present invention provides the bovine melanocortin 4 receptor protein (MC4-R), peptide and polypeptide fragments thereof, as well as nucleic acids encoding these molecules. Also provided are recombinant vectors comprising these nucleic acids, and recombinant host cells containing such vectors. Also provided are methods for identifying selective agonists and antagonists of bovine MC4-R, compounds that modulate the activity or expression of the bovine MC4-R, and methods for modifying body weight in bovine animals utilizing the bovine MC4-R as the target for intervention.

Uses Of Melanocortin-3 Receptor (Mc3R) Agonist Peptides

View page
US Patent:
20060293223, Dec 28, 2006
Filed:
Jun 17, 2004
Appl. No.:
10/556690
Inventors:
Robert Gadski - Indianapolis IN, US
Mark Heiman - Indianapolis IN, US
Hansen Hsiung - Indianapolis IN, US
John Mayer - Indianapolis IN, US
Liang Yan - Carmel IN, US
Assignee:
Eli Lilly and Company Patent Division - Indianapolis IN
International Classification:
A61K 38/12
US Classification:
514009000
Abstract:
The present invention provides methods of treating metabolic disorders, including, for example, obesity, diabetes mellitus, cachexia, sarcopenia, and cardiovascular disorders, methods of inducing weight loss and increasing muscle mass in a patient, by administration of MC3R agonist peptides. Furthermore, the present invention provides the use of an MC3R agonist peptide for the manufacture of a medicament for the treatment of metabolic disorders, including, for example, obesity, diabetes mellitus, cachexia, sarcopenia, and cardiovascular disorders, inducing weight loss and increasing muscle mass in a patient.

Melanocortin Receptor 4 (Mc4) Agonists And Their Uses

View page
US Patent:
20070105759, May 10, 2007
Filed:
Jun 17, 2004
Appl. No.:
10/556689
Inventors:
David Flora - Greenfield IN, US
Mark Heiman - Indianapolis IN, US
JeAnne Hertel - Indianapolis IN, US
Hansen Hsiung - Indianapolis IN, US
John Mayer - Indianapolis IN, US
David Smiley - Greenfield IN, US
Liang Yan - Carmel IN, US
Lianshan Zhang - Carmel IN, US
Assignee:
ELI LILLY AND COMPANY - INDIANAPOLIS IN
International Classification:
A61K 38/12
C07K 7/64
US Classification:
514009000, 530317000
Abstract:
The present invention relates to peptide agonists of the MC4 receptor, and as such are useful in the treatment of disorders responsive to the activation of this receptor, such as obesity, diabetes mellitus and male and/or female sexual dysfunction.

Novel Expression Control Sequences

View page
US Patent:
47957069, Jan 3, 1989
Filed:
Jan 31, 1985
Appl. No.:
6/697093
Inventors:
Hansen M. Hsiung - Indianapolis IN
Dennis P. Smith - Indianapolis IN
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
C12N 1500
C12N 120
C12P 2100
C07H 1512
US Classification:
4351723
Abstract:
The present invention comprises novel expression control sequences that promote transcription of DNA. The novel sequences have been positioned for expression of structural genes encoding bovine growth hormone derivatives on recombinant DNA expression vectors. The novel expression control sequences function in both Gram-positive and Gram-negative organisms and can be constructed by either DNA synthesizing instruments or by conventional modified phosphotriester methodology.

Process For Isolating Oligonucleotide Product From A Coupling Reaction Mixture

View page
US Patent:
44170467, Nov 22, 1983
Filed:
Aug 24, 1981
Appl. No.:
6/295419
Inventors:
Hansen M. Hsiung - Indianapolis IN
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
C07H 1512
C07H 1700
US Classification:
536 27
Abstract:
A polynucleotide product produced by coupling in the presence of a coupling agent (1) a nucleotide or oligonucleotide having a blocked 5'-hydroxyl group and a 3'-phosphate diester group and (2) a nucleotide or oligonucleotide having a blocked 3'-hydroxyl or a blocked 3'-phosphate diester group and a free 5'-hydroxyl group is recovered from the reaction mixture by addition of an organic solvent or mixture of organic solvents which precipitates the polynucleotide product from the reaction mixture while retaining the coupling agent in solution.

Derivative Of The Tryptophan Operon For Expression Of Fused Gene Products

View page
US Patent:
47389214, Apr 19, 1988
Filed:
Sep 27, 1984
Appl. No.:
6/655183
Inventors:
Ramamoorthy Belagaje - Indianapolis IN
Janet K. Epp - Indianapolis IN
JoAnn Hoskins - Indianapolis IN
Hansen M. Hsiung - Indianapolis IN
George L. Long - Indianapolis IN
Brigitte E. Schoner - Zionsville IN
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
C12P 2100
C12P 2102
C12N 1500
C12N 120
C12N 700
C07H 1512
US Classification:
435 68
Abstract:
The present invention comprises improved derivatives of the tryptophan operon useful for expressing fused gene products in E. coli and relate organism. Two of the improved derivatives disclosed are encoded on 0. 43 and 0. 55 kb EcoRI restriction fragments from plasmids pCZ20 and pLEBGH2 (in strains NRRL B-15881 and NRRL B-15882), respectively. The modified derivatives have been placed on recombinant DNA cloning and expression vectors. A variety of expression vectors have been constructed that drive expression of fused gene products. Two novel gene sequences, encoding insulin-like growth factors I and II, have been expressed with the modified tryptophan operon system.

Bacteriophage Lambda Pl Promoters

View page
US Patent:
55761909, Nov 19, 1996
Filed:
Nov 23, 1993
Appl. No.:
8/156325
Inventors:
Rama M. Belagaje - Indianapolis IN
Charles L. Hershberger - New Palestine IN
Hansen M. Hsiung - Carmel IN
Paul R. Rosteck - Indianapolis IN
Jane L. Sterner - Indianapolis IN
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
C12N 121
C12N 1511
C12N 1567
C12N 1573
US Classification:
435 691
Abstract:
The present invention concerns novel DNA compounds which function as transcriptional activating sequences. Recombinant DNA expression vectors which contain the transcriptional activating sequences and host cells transformed with these expression vectors are also provided. When properly positioned in an expression vector, the novel transcriptional activating sequences enable regulatable expression of an operably linked gene and enhance the structural stability of the expression vector.

Process For De-Cyanoethylating Blocked Nucleotides

View page
US Patent:
44265174, Jan 17, 1984
Filed:
Aug 24, 1981
Appl. No.:
6/295420
Inventors:
Hansen M. Hsiung - Indianapolis IN
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
C07H 1512
C07H 1700
US Classification:
536 27
Abstract:
A. beta. -cyanoethyl blocking group is selectively removed from the phosphate moiety of a nucleotide or polynucleotide by treatment with diethyl amine.
Control profile
Hansen M Hsiung from San Jose, CA, age ~77 Get Report